id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-317846-str9i01o	Chen, Dr. Xian	Mesenchymal stem cell therapy in severe COVID-19: a retrospective study of short-term treatment efficacy and side effects	2020-05-15		.txt	text/plain	1108	77	58	title: Mesenchymal stem cell therapy in severe COVID-19: a retrospective study of short-term treatment efficacy and side effects Therefore, diminishing the cytokine storm may be an important part of treatment in patients with severe COVID-19 [4] . On this basis, we conducted a retrospective study to evaluate the treatment efficacy and side effects of MSCs therapy on severe COVID-19. In our series, all the patients with severe COVID-19 survived and entered recovery after MSCs therapy, and only 3 patients experienced treatment side effects. Firstly, inflammation indexes, such as WBC counts and CRP were totally normal before MSCs therapy in most cases, which means that cytokine storm was mild to moderate and not serious in these cases. In conclusion, we suggested that MSCs therapy might be a promising option for the treatment of severe COVID-19, but should be used cautiously, especially in patients with metabolic acidosis or coronary heart disease.	./cache/cord-317846-str9i01o.txt	./txt/cord-317846-str9i01o.txt